Hims Hers Health Inc

$55.25
(as of Jun 10, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Hims Hers Health Inc

Stock Price
$55.25
Ticker Symbol
HIMS
Exchange
NYSE

Industry Information for Hims Hers Health Inc

Sector
Consumer Defensive
Industry
Household & Personal Products

Company Description for Hims Hers Health Inc

Country
USA
Full Time Employees
1,637

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Fundamentals for Hims Hers Health Inc

Market Capitalization
$12,608,456,704
EBITDA
$137,678,000
Dividends per Share
P/E Ratio
82.84
Forward P/E Ratio
93.46
Earnings per Share
$0.68
Earnings per Share Estimate Next Year
Profit Margin
9.21%
Shares Outstanding
215,454,000
Percent Owned by Insiders
11.08%
Percent Owned by Institutions
74.34%
52-Week High
52-Week Low

Technical Indicators for Hims Hers Health Inc

50-Day Moving Average
200-Day Moving Average
RSI
55.77
4.92

Analyst Ratings for Hims Hers Health Inc

Strong Buy
4
Buy
1
Hold
6
Sell
1
Strong Sell
1

News About Hims Hers Health Inc

Jun 10, 2025, 4:27 PM EST
Eli Lilly (LLY) revealed a new stipulation regarding its business dealings with telehealth companies Ro and LifeMD (LFMD), ensuring that compounded versions of its GLP-1 weight-loss drugs are not being sold on these sites. See more.
Jun 10, 2025, 3:35 PM EST
Investing.com -- Hims & Hers Health Inc (NYSE:HIMS) stock fell 3.8% Tuesday after Eli Lilly and Company (NYSE:LLY) indicated it would not partner with telehealth firms selling copycat versions of weight-loss drugs, effectively ruling out a potential deal with Hims. See more.
Jun 8, 2025, 6:50 PM EST
Key Points See more.
Jun 8, 2025, 6:50 PM EST
Many companies have failed to disrupt the complicated U.S. healthcare market. See more.